Invention Grant
- Patent Title: Substituted quinazolinone compounds
- Patent Title (中): 取代喹唑啉酮化合物
-
Application No.: US10850967Application Date: 2004-05-21
-
Publication No.: US07625909B2Publication Date: 2009-12-01
- Inventor: Rustum S. Boyce , Natalia Aurrecoechea , Daniel Chu , Aaron Smith , Christopher R. Conlee , Brian D. Thompson , Judith de Armas Kuntz , David L. Musso , Kevin K. Barvian , Stephen A. Thomson , William R. Swain , Kien S. Du , Brian A. Chauder , Jason D. Speake , Michael J. Bishop
- Applicant: Rustum S. Boyce , Natalia Aurrecoechea , Daniel Chu , Aaron Smith , Christopher R. Conlee , Brian D. Thompson , Judith de Armas Kuntz , David L. Musso , Kevin K. Barvian , Stephen A. Thomson , William R. Swain , Kien S. Du , Brian A. Chauder , Jason D. Speake , Michael J. Bishop
- Applicant Address: US CA Emeryville
- Assignee: Novartis Vaccines and Diagnostics, Inc.
- Current Assignee: Novartis Vaccines and Diagnostics, Inc.
- Current Assignee Address: US CA Emeryville
- Agent Vinit Kathardekar; Joseph Meara
- Main IPC: A61K31/517
- IPC: A61K31/517 ; A61K31/519 ; A61P5/50 ; C07D239/88 ; C07D239/95 ; C07D471/04 ; C07D487/04
Abstract:
A variety of small molecule, guanidine-containing molecules capable of acting as MC4-R agonists are provided. The compounds are useful in treating MC4-R mediated diseases when administered to subjects. The compounds have the structure IA, IB, and IC where the values of the variables are defined herein.
Public/Granted literature
- US20050059662A1 Substituted quinazolinone compounds Public/Granted day:2005-03-17
Information query
IPC分类:
